A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer

NCT06398405 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Dysphagia, Esophageal
Epigallocatechin Gallate

Interventions

OTHER: Epigallocatechin-3-gallate

Sponsor

Shandong Cancer Hospital and Institute